Literature DB >> 10103193

Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.

S Bagel1, V Hüllen, B Wiedemann, P Heisig.   

Abstract

Isogenic mutants derived from quinolone-susceptible isolate WT by introducing gyrA (S83L, D87G) and parC (S80I, E84K) mutations associated with quinolone resistance were characterized with respect to quinolone resistance, growth rate, and degree of global supercoiling. The latter was determined by use of a pair of reporter plasmids carrying supercoiling-dependent promoters pgyrA and ptopA, respectively, transcriptionally fused to the reporter gene bla coding for TEM-1 beta-lactamase. The quotient (Qsc) of the beta-lactamase specific activity determined for a mutant carrying either plasmid was taken as a measure of the degree of global supercoiling. These Qsc data were comparable to results obtained from the separation of topoisomers of plasmid pBR322 on chloroquine-containing agarose gels and indicate a reduced degree of negative supercoiling in resistant mutants relative to the parent, WT. The S83L mutation in gyrA had the strongest influence on quinolone resistance while leaving other parameters nearly unaffected. The gyrA double mutation (S83L plus D87G) had an effect on quinolone resistance similar to that of a single mutation. Phenotypic expression of the parC mutation (S80I) was dependent on the presence of at least one gyrA mutation. Expression of high-level fluoroquinolone resistance (ciprofloxacin MIC, > 4 micrograms/ml) required a combination of the gyrA double mutation and one parC mutation (S80I or E84K). Such mutants showed considerable alterations of growth rate, global supercoiling, or both. Introduction of a parC mutation affected neither the doubling time nor the degree of supercoiling, while the presence of the gyrA D87G mutation was associated with a significant reduction in the degree of DNA supercoiling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103193      PMCID: PMC89219     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  54 in total

1.  gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.

Authors:  S Nakamura; M Nakamura; T Kojima; H Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  DNA supercoiling in Escherichia coli: topA mutations can be suppressed by DNA amplifications involving the tolC locus.

Authors:  C J Dorman; A S Lynch; N Ni Bhriain; C F Higgins
Journal:  Mol Microbiol       Date:  1989-04       Impact factor: 3.501

3.  New method for generating deletions and gene replacements in Escherichia coli.

Authors:  C M Hamilton; M Aldea; B K Washburn; P Babitzke; S R Kushner
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

4.  Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.

Authors:  S P Cohen; L M McMurry; D C Hooper; J S Wolfson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 5.  Mechanisms of action of and resistance to ciprofloxacin.

Authors:  D C Hooper; J S Wolfson; E Y Ng; M N Swartz
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Authors:  S P Cohen; D C Hooper; J S Wolfson; K S Souza; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

7.  Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.

Authors:  G J Pruss; R J Franco; S G Chevalier; S H Manes; K Drlica
Journal:  J Bacteriol       Date:  1986-10       Impact factor: 3.490

8.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

9.  Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.

Authors:  M E Cullen; A W Wyke; R Kuroda; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

10.  New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.

Authors:  V Aleixandre; A Urios; G Herrera; M Blanco
Journal:  Mol Gen Genet       Date:  1989-10
View more
  76 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants.

Authors:  Vito Ricci; Marnie L Peterson; John C Rotschafer; Hannah Wexler; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

3.  Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agents.

Authors:  Anne Liu; Amie Fong; Elinne Becket; Jessica Yuan; Cindy Tamae; Leah Medrano; Maria Maiz; Christine Wahba; Catherine Lee; Kim Lee; Katherine P Tran; Hanjing Yang; Robert M Hoffman; Anya Salih; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

4.  The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.

Authors:  Sachin S Bhagwat; Lakshmi A Mundkur; Shrikant V Gupte; Mahesh V Patel; Habil F Khorakiwala
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

5.  Fluoroquinolone-resistant mutants of Burkholderia cepacia.

Authors:  C F Pope; S H Gillespie; J R Pratten; T D McHugh
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

6.  Differential phenotypic and genotypic characteristics of qnrS1-harboring plasmids carried by hospital and community commensal enterobacteria.

Authors:  Le Thi Minh Vien; Manal Abuoun; Victoria Morrison; Nicholas Thomson; James I Campbell; Martin J Woodward; Nguyen Van Vinh Chau; Jeremy Farrar; Constance Schultsz; Stephen Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

7.  Cost of adaptation and fitness effects of beneficial mutations in Pseudomonas fluorescens.

Authors:  Thomas Bataillon; Tianyi Zhang; Rees Kassen
Journal:  Genetics       Date:  2011-08-25       Impact factor: 4.562

8.  Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications.

Authors:  Priyanka Bajaj; Pawan Kumar Kanaujia; Nambram Somendro Singh; Shalu Sharma; Shakti Kumar; Jugsharan Singh Virdi
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-26       Impact factor: 4.223

9.  Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China.

Authors:  Hanchun Yang; Sheng Chen; David G White; Shaohua Zhao; Patrick McDermott; Robert Walker; Jianghong Meng
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin.

Authors:  Jacob Strahilevitz; Amos Adler; Gillian Smollan; Violeta Temper; Nathan Keller; Colin Block
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.